Pharmanutra S.p.A. (BIT:PHN)
Italy
· Delayed Price · Currency is EUR 79.10
+0.40 (0.51%)
Apr 28, 2026, 5:35 PM CET
Pharmanutra Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 131.69 | 115.5 | 100.2 | 82.72 | 68.11 | Upgrade
|
| Other Revenue | 0.47 | 0.65 | 0.5 | 0.34 | 0.03 | Upgrade
|
| Revenue | 132.16 | 116.15 | 100.71 | 83.06 | 68.14 | Upgrade
|
| Revenue Growth (YoY) | 13.78% | 15.33% | 21.24% | 21.89% | 20.04% | Upgrade
|
| Cost of Revenue | 65.37 | 56.91 | 52.09 | 41.14 | 35.99 | Upgrade
|
| Gross Profit | 66.79 | 59.24 | 48.62 | 41.92 | 32.15 | Upgrade
|
| Selling, General & Admin | 32.71 | 26.67 | 22.55 | 17.19 | 12.12 | Upgrade
|
| Other Operating Expenses | 1.41 | 1.81 | 0.43 | 0.34 | 0.34 | Upgrade
|
| Operating Expenses | 37.69 | 31.88 | 25.6 | 18.84 | 13.86 | Upgrade
|
| Operating Income | 29.1 | 27.36 | 23.02 | 23.07 | 18.3 | Upgrade
|
| Interest Expense | -0.66 | -1.06 | -0.8 | -0.06 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.52 | 0.68 | 0.32 | 0.13 | 0.15 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.08 | -0.04 | 0.08 | -0.03 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.64 | 0.77 | 1.17 | 0.34 | 0.4 | Upgrade
|
| EBT Excluding Unusual Items | 30.52 | 27.71 | 23.79 | 23.45 | 18.83 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | -0.27 | -0.03 | -0.03 | -0.02 | Upgrade
|
| Legal Settlements | -0.33 | -0.27 | -0.5 | - | - | Upgrade
|
| Pretax Income | 30.19 | 27.16 | 23.26 | 23.42 | 18.81 | Upgrade
|
| Income Tax Expense | 10.27 | 10.61 | 10.43 | 8.37 | 5.04 | Upgrade
|
| Earnings From Continuing Operations | 19.92 | 16.55 | 12.83 | 15.05 | 13.77 | Upgrade
|
| Minority Interest in Earnings | 0.09 | 0.06 | - | - | - | Upgrade
|
| Net Income | 20 | 16.61 | 12.83 | 15.05 | 13.77 | Upgrade
|
| Net Income to Common | 20 | 16.61 | 12.83 | 15.05 | 13.77 | Upgrade
|
| Net Income Growth | 20.44% | 29.43% | -14.73% | 9.27% | -2.14% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | -0.16% | -0.67% | -0.05% | -0.09% | - | Upgrade
|
| EPS (Basic) | 2.09 | 1.73 | 1.33 | 1.56 | 1.42 | Upgrade
|
| EPS (Diluted) | 2.09 | 1.73 | 1.33 | 1.56 | 1.42 | Upgrade
|
| EPS Growth | 20.63% | 30.29% | -14.69% | 9.37% | -2.13% | Upgrade
|
| Free Cash Flow | 16.43 | 16.17 | -1.16 | -8.69 | 15.43 | Upgrade
|
| Free Cash Flow Per Share | 1.71 | 1.68 | -0.12 | -0.90 | 1.59 | Upgrade
|
| Dividend Per Share | 1.200 | 1.000 | 0.850 | 0.800 | 0.710 | Upgrade
|
| Dividend Growth | 20.00% | 17.65% | 6.25% | 12.68% | 5.97% | Upgrade
|
| Gross Margin | 50.54% | 51.00% | 48.28% | 50.47% | 47.18% | Upgrade
|
| Operating Margin | 22.02% | 23.55% | 22.86% | 27.78% | 26.85% | Upgrade
|
| Profit Margin | 15.14% | 14.30% | 12.74% | 18.12% | 20.21% | Upgrade
|
| Free Cash Flow Margin | 12.43% | 13.92% | -1.15% | -10.46% | 22.64% | Upgrade
|
| EBITDA | 31.82 | 30.87 | 25.44 | 24.22 | 19.3 | Upgrade
|
| EBITDA Margin | 24.08% | 26.58% | 25.26% | 29.16% | 28.33% | Upgrade
|
| D&A For EBITDA | 2.72 | 3.51 | 2.42 | 1.15 | 1.01 | Upgrade
|
| EBIT | 29.1 | 27.36 | 23.02 | 23.07 | 18.3 | Upgrade
|
| EBIT Margin | 22.02% | 23.55% | 22.86% | 27.78% | 26.85% | Upgrade
|
| Effective Tax Rate | 34.03% | 39.06% | 44.83% | 35.74% | 26.78% | Upgrade
|
| Revenue as Reported | 133.97 | 116.91 | 101.96 | 83.39 | 68.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.